Evidence map›Paper›PMID 11739736›Full record

ArticleMolecular and cellular biology2002

Characterization of U2AF(6), a splicing factor related to U2AF(35).

Jeremiah Shepard, Martin Reick, Sara Olson, Brenton R Graveley

Abstract read
In one paragraph

Article in Molecular and cellular biology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. iScience · 2022
    Article
  4. Article
  5. Postsplicing-Derived Full-Length Intron Circles in the Protozoan ParasiteFrontiers in cellular and infection microbiology · 2018
    Article
  6. Diverse regulation of 3' splice site usage.Cellular and molecular life sciences : CMLS · 2015
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jeremiah ShepardDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Martin Reick
Sara Olson
Brenton R Graveley

Funding

GENETICS &BIOCHEMISTRY OF NEURONAL PAS DOMAIN PROTEINSR37MH059388 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI MCKNIGHT, STEVEN L · 2000 to 2008
$4.7M
The Mechanisms and Regulatory Networks of Alternative Splicing in DrosophilaR01GM062516 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI GRAVELEY, BRENTON R. · 2001 to 2009
$2.6M
NIGMS NIH HHS R01 GM062516NIGMS NIH HHS R01 GM62516-01NIMH NIH HHS 5 R37 MH59388-03NIMH NIH HHS R37 MH059388
6 · The paper itself

Abstract

The essential splicing factor U2AF (U2 auxiliary factor) is a heterodimer composed of 65-kDa (U2AF(65)) and 35-kDa (U2AF(35)) subunits. U2AF(35) has multiple functions in pre-mRNA splicing. First, U2AF(35) has been shown to function by directly interacting with the AG at the 3' splice site. Second, U2AF(35) is thought to play a role in the recruitment of U2AF(65) by serine-arginine-rich (SR) proteins in enhancer-dependent splicing. It has been proposed that the physical interaction between the arginine-serine-rich (RS) domain of U2AF(35) and SR proteins is important for this activity. However, other data suggest that this may not be the case. Here, we report the identification of a mammalian gene that encodes a 26-kDa protein bearing strong sequence similarity to U2AF(35), designated U2AF(26). The N-terminal 187 amino acids of U2AF(35) and U2AF(26) are nearly identical. However, the C-terminal domain of U2AF(26) lacks many characteristics of the U2AF(35) RS domain and, therefore, might be incapable of interacting with SR proteins. We show that U2AF(26) can associate with U2AF(65) and can functionally substitute for U2AF(35) in both constitutive and enhancer-dependent splicing, demonstrating that the RS domain of the small U2AF subunit is not required for splicing enhancer function. Finally, we show that U2AF(26) functions by enhancing the binding of U2AF(65) to weak 3' splice sites. These studies identify U2AF(26) as a mammalian splicing factor and demonstrate that distinct U2AF complexes can participate in pre-mRNA splicing. Based on its sequence and functional similarity to U2AF(35), U2AF(26) may play a role in regulating alternative splicing.

Indexed as

Nuclear ProteinsAmino Acid SequenceAnimalsCell FractionationCloning, MolecularHeLa CellsHumansImmunohistochemistryMiceMolecular Sequence DataProtein BindingProtein Structure, TertiaryProtein SubunitsRibonucleoproteinsRNA Splice SitesRNA SplicingNuclear ProteinsProtein SubunitsRibonucleoproteinsRNA Splice SitesSplicing Factor U2AFU2af1l4 protein, mouseU2AF2 protein, humanZrsr1 protein, mouse

Identifiers

PMID11739736
PMCPMC134218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.